![Nadia Agopyan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nadia Agopyan
No open positions remaining
Profile
Nadia Agopyan formerly worked at Janssen Oncology, Inc., as Director-Regulatory Affairs, Kite Pharma, Inc., as Director-Regulatory Affairs from 2015 to 2019, Ambit Biosciences Corp., as Senior Director-Regulatory Affairs from 2010 to 2012, Baxter BioScience Corp., as Head-Global Regulatory Affairs from 2012 to 2015, Duke University, as Assistant Professor from 2000 to 2003, the University of Toronto, as Assistant Professor from 1996 to 2000, and Marker Therapeutics, Inc., as Vice President-Regulatory Affairs from 2019 to 2024.
Dr. Agopyan received her undergraduate degree and doctorate degree from McGill University.
Former positions of Nadia Agopyan
| Companies | Position | End |
|---|---|---|
| MARKER THERAPEUTICS, INC. | General Counsel | 2024-02-29 |
| KITE PHARMA INC | Corporate Officer/Principal | 2019-07-31 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Corporate Officer/Principal | 2015-03-31 |
| AMBIT BIOSCIENCES CORP | General Counsel | 2012-01-31 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2002-12-31 |
Training of Nadia Agopyan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
- Stock Market
- Insiders
- Nadia Agopyan
